Literature DB >> 1705884

Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid.

S S Rhee1, E Hunter.   

Abstract

The functional roles of the matrix (MA) protein in the assembly and maturation of retroviruses was investigated with a series of MA mutants of Mason-Pfizer monkey virus (M-PMV), an immunosuppressive type D retrovirus. The mutants we describe here were generated by the introduction of random point mutations within the MA coding domain by use of sodium bisulphite mutagenesis. Studies of these mutants show that the MA protein plays a critical role in three different, sequential events in the final stages of type D retrovirus replication: (i) folding of the gag gene-encoded precursor poly-proteins into a stable conformation for capsid assembly in the cytoplasm of infected cells; (ii) capsid transport from the site of assembly to the plasma membrane; and (iii) capsid association with, and extrusion of the membrane during virus budding. The mutants described here interfere with or block M-PMV replication at each of these stages. Large numbers of preassembled capsids accumulate within the cytoplasm of transport-defective mutant-infected cells, suggesting that transport of M-PMV capsids to the plasma membrane is an active and specific intracellular targeting process. The initial association of the capsid with the membrane may depend upon this intracytoplasmic transport process but additional protein-lipid interactions that involve the MA protein are required for membrane extrusion around the preformed capsids; in cells infected with the budding-defective mutant, assembled capsids accumulate under the inner surface of the cell plasma membrane, and are retarded in their release from the infected cell.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705884      PMCID: PMC452681          DOI: 10.1002/j.1460-2075.1991.tb07980.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Myristoylation of budgerigar fledgling disease virus capsid protein VP2.

Authors:  M Schmidt; H Müller; M F Schmidt; R Rott
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

2.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

Review 3.  The biology and enzymology of eukaryotic protein acylation.

Authors:  D A Towler; J I Gordon; S P Adams; L Glaser
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

5.  Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus.

Authors:  P Sonigo; C Barker; E Hunter; S Wain-Hobson
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

6.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

7.  Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).

Authors:  L E Henderson; R E Benveniste; R Sowder; T D Copeland; A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products.

Authors:  J Bradac; E Hunter
Journal:  Virology       Date:  1984-10-30       Impact factor: 3.616

9.  Molecular cloning of the Mason-Pfizer monkey virus genome: characterization and cloning of subgenomic fragments.

Authors:  C S Barker; J W Wills; J A Bradac; E Hunter
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

10.  Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products.

Authors:  J W Wills; R V Srinivas; E Hunter
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  53 in total

1.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy.

Authors:  S D Parker; J S Wall; E Hunter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.

Authors:  E C Jørgensen; F S Pedersen; P Jørgensen
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.

Authors:  R J Owens; J W Dubay; E Hunter; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.

Authors:  X Yu; X Yuan; Z Matsuda; T H Lee; M Essex
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging.

Authors:  Anna K Overby; Ralf F Pettersson; Etienne P A Neve
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.

Authors:  E J Platt; O K Haffar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  T Dorfman; F Mammano; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.